Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > The best on Stockhouse

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Aug 04, 2021 4:41pm

115 Views

Post# 33649813

RE:The best on Stockhouse

Only thing I see on the rise is the number of boring posts you are putting out there. Maybe look for some new material or we will all nod off.............

4real4ever wrote:

gojotv! (1112)

User Actions

August 03, 2021 - 01:20 PM

70 Reads

Post# 33642779

Into the 0.50's this week...

Or so it looks...Maybe even the 0.60's if word gets out about bolstered management, the confidence yet another life sciences expert has in SZLSF's future, and the merger finalization coupled with Q2 financials. We're on the rise again!